Oragenics Inc.

AMEX: OGEN · Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Aug 15, 2025, 3:59 PM
1.17
2.61%
After-hours: Aug 15, 2025, 07:37 PM EDT

Oragenics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-10.57M -20.66M -14.29M -15.71M
Depreciation & Amortization
n/a 27.39K 44.67K 41.24K
Stock-Based Compensation
516.05K 1.02M 742.2K 1.69M
Other Working Capital
1.57M 1.99M -1.89M 501.59K
Other Non-Cash Items
n/a 10.33M -10.96K 1.77M
Deferred Income Tax
n/a n/a n/a -1.77M
Change in Working Capital
1.45M 1.99M -1.72M 512.14K
Operating Cash Flow
-8.6M -7.29M -15.23M -13.47M
Capital Expenditures
n/a n/a -127.52K -43.88K
Cash Acquisitions
n/a n/a 12K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -936.28K n/a n/a
Investing Cash Flow
n/a -936.28K -115.52K -43.88K
Debt Repayment
-693.11K -566.05K -564.21K -524.98K
Common Stock Repurchased
n/a n/a n/a -5.64M
Dividend Paid
n/a n/a n/a -1.12M
Other Financial Acitivies
n/a n/a n/a 1.12M
Financial Cash Flow
5.98M 283.88K -494.92K 23.14M
Net Cash Flow
-2.62M -7.94M -15.84M 9.63M
Free Cash Flow
-8.6M -7.29M -15.36M -13.51M